Tagliari Ana Paula, Taramasso Maurizio
Instituto de Ciências Biológicas e da Saúde, Universidade Federal do Rio Grande do Sul, 90046-900 Porto Alegre, Brazil.
Cardiac Surgery Department, Hospital Mãe de Deus, 90880-481 Porto Alegre, Brazil.
Rev Cardiovasc Med. 2024 May 21;25(5):180. doi: 10.31083/j.rcm2505180. eCollection 2024 May.
Tricuspid regurgitation, once considered a relatively benign condition, has now gathered significant attention due to new evidence showing its impact on both short- and long-term follow-up. While surgical intervention remains the established standard approach for treating severe tricuspid regurgitation, current guidelines provide Class I indication for intervention in only a limited set of scenarios. This review delves into the present and future perspectives of surgical tricuspid regurgitation management, examining aspects such as disease prognosis, surgical indications, outcomes, and a comprehensive overview of past and upcoming clinical trials.
三尖瓣反流曾被认为是一种相对良性的病症,但由于新证据表明其对短期和长期随访均有影响,如今已备受关注。虽然手术干预仍是治疗严重三尖瓣反流的既定标准方法,但当前指南仅在有限的一组情况下提供I类干预指征。本综述深入探讨了手术治疗三尖瓣反流的现状和未来前景,研究了疾病预后、手术指征、治疗效果等方面,并全面概述了过去和即将开展的临床试验。